Trurapi (insulin aspart)

pCPA File Number: 22347
Negotiation Status:
Concluded with an LOI
Indication(s):
• the treatment of patients with diabetes mellitus who require insulin for the control of hyperglycemia (normally to be used in regimens together with an intermediate or long-acting insulin)
• continuous subcutaneous insulin infusion (CSII) in pump systems which are licensed in Canada for Trurapi insulin infusion
Sponsor/Manufacturer:
sanofi-aventis Canada Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: